{"id":"https://openalex.org/W2147273166","doi":"https://doi.org/10.2215/cjn.01040905","title":"Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker","display_name":"Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker","alternate_titles":[],"publication_year":2006,"publication_date":"2006-02-01","ids":{"openalex":"https://openalex.org/W2147273166","doi":"https://doi.org/10.2215/cjn.01040905","mag":"2147273166","pmid":"https://pubmed.ncbi.nlm.nih.gov/17699214"},"language":"en","primary_location":{"id":"doi:10.2215/cjn.01040905","doi":"https://doi.org/10.2215/cjn.01040905","is_oa":false,"landing_page_url":"https://doi.org/10.2215/cjn.01040905","pdf_url":null,"source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147273166"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112369105","display_name":"Anastasia Chrysostomou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Anastasia Chrysostomou","raw_affiliation_strings":["Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria 3052, Australia. anastasiac@optusnet.com.au"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Royal Melbourne Hospital, Parkville, Victoria 3052, Australia. anastasiac@optusnet.com.au","institution_ids":["https://openalex.org/I1320473756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034705822","display_name":"Eugenia Pedagogos","orcid":"https://orcid.org/0009-0003-9019-8646","observed_orcids":["https://orcid.org/0009-0003-9019-8646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugenia Pedagogos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111637658","display_name":"Lachlan MacGregor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lachlan MacGregor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110069286","display_name":"Gavin J. Becker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin J. Becker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":15.1732,"has_fulltext":false,"cited_by_count":220,"citation_normalized_percentile":{"value":0.99253085,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"1","issue":"2","first_page":"256","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.4587000012397766,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.4587000012397766,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.19789999723434448,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.1647000014781952,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spironolactone","display_name":"spironolactone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9269999861717224},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8790000081062317},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ramipril","display_name":"ramipril","score":0.8949999809265137},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":0.8560000061988831},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system-blockade","display_name":"renin-angiotensin-aldosterone system blockade","score":0.9739999771118164},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/dual-therapy","display_name":"dual therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6639999747276306},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2779888176","wikidata":"https://www.wikidata.org/wiki/Q412666","display_name":"Ramipril","level":3,"score":0.9100614786148071},{"id":"https://openalex.org/C2776379505","wikidata":"https://www.wikidata.org/wiki/Q422188","display_name":"Spironolactone","level":3,"score":0.8664213418960571},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.8225619196891785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7944711446762085},{"id":"https://openalex.org/C189135053","wikidata":"https://www.wikidata.org/wiki/Q3454531","display_name":"Mineralocorticoid receptor","level":3,"score":0.6273857355117798},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5900940299034119},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.5766439437866211},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5495766401290894},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5293859839439392},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5062453150749207},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5018858909606934},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4393481910228729},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.4350239932537079},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4208931624889374},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.4108428657054901},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.25766438245773315},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16539880633354187},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.12835833430290222},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2215/cjn.01040905","doi":"https://doi.org/10.2215/cjn.01040905","is_oa":false,"landing_page_url":"https://doi.org/10.2215/cjn.01040905","pdf_url":null,"source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmid:17699214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17699214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical journal of the American Society of Nephrology : CJASN","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.622.4325","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.622.4325","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cjasn.asnjournals.org/content/1/2/256.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1972067117","https://openalex.org/W1974018564","https://openalex.org/W1998038903","https://openalex.org/W2000060059","https://openalex.org/W2003508199","https://openalex.org/W2019270553","https://openalex.org/W2023943834","https://openalex.org/W2027790713","https://openalex.org/W2031187741","https://openalex.org/W2042663838","https://openalex.org/W2044773944","https://openalex.org/W2045790461","https://openalex.org/W2074391878","https://openalex.org/W2075429282","https://openalex.org/W2090526184","https://openalex.org/W2110754607","https://openalex.org/W2118932957","https://openalex.org/W2127642431","https://openalex.org/W2135856179","https://openalex.org/W2137561245","https://openalex.org/W2140745413","https://openalex.org/W2143144750","https://openalex.org/W2160541810","https://openalex.org/W2163709605","https://openalex.org/W2312400976","https://openalex.org/W2615684303","https://openalex.org/W3156148333"],"related_works":["https://openalex.org/W281788183","https://openalex.org/W1997676536","https://openalex.org/W2010677852","https://openalex.org/W1963930171","https://openalex.org/W2074476571","https://openalex.org/W2520863505","https://openalex.org/W2889713004","https://openalex.org/W2077291694","https://openalex.org/W4232265677"],"abstract_inverted_index":{"Studies":[0],"have":[1],"shown":[2],"that":[3,34,143,153,200],"dual":[4,48,71,227],"therapy":[5,49,66,213],"with":[6,50,64,84,211],"angiotensin-converting":[7],"enzyme":[8],"inhibitors":[9],"(ACEI)":[10],"and":[11,115,175,194],"either":[12,28],"angiotensin":[13],"II":[14],"receptor":[15,19,202],"blockers":[16],"or":[17],"aldosterone":[18,201],"antagonists":[20],"is":[21],"more":[22],"effective":[23],"in":[24,81,125,146,150,158,181],"reducing":[25],"proteinuria":[26,85,159,182],"than":[27],"agent":[29],"used":[30,46,210],"alone.":[31],"The":[32,122,156,179],"questions":[33],"remain":[35],"are":[36],"as":[37,47,164],"follows:":[38,165],"(1)":[39,93],"Which":[40],"of":[41,58,60,217,223,229],"these":[42],"agents":[43],"should":[44],"be":[45],"the":[51,61,215,230],"ACEI?":[52],"(2)":[53,101],"Does":[54],"a":[55,205],"higher":[56],"level":[57],"blockade":[59,203,225,228],"renin-angiotensin-aldosterone":[62,231],"system":[63,232],"triple":[65,224],"offer":[67],"an":[68],"advantage":[69,222],"over":[70,226],"blockade?":[72],"A":[73],"3-mo":[74],"randomized,":[75],"double-blind,":[76],"placebo-controlled":[77],"study":[78,198],"was":[79,163,190],"performed":[80],"41":[82],"patients":[83,184],">1.5":[86],"g/d.":[87],"Four":[88],"treatment":[89,131,151,208],"groups":[90],"were":[91,186],"compared:":[92],"Ramipril":[94],"+":[95,98,103,105,110,113,118,120],"spironolactone":[96,106],"placebo":[97,112],"irbesartan":[99,104,111,119],"placebo,":[100,107],"ramipril":[102,109,117],"(3)":[108],"spironolactone,":[114],"(4)":[116],"spironolactone.":[121,155],"percentage":[123],"change":[124],"protein":[126,147],"excretion":[127,148],"differed":[128],"according":[129],"to":[130,233],"arm":[132],"(ANOVA:":[133],"F(3,35)":[134],"=":[135],"8.6,":[136],"P":[137],"<":[138],"0.001).":[139],"Pair-wise":[140],"comparison":[141],"showed":[142],"greater":[144],"reduction":[145,157,180,216],"occurred":[149],"regimens":[152,189],"incorporated":[154],"at":[160,192],"3":[161],"mo":[162],"Group":[166],"1,":[167],"1.4%;":[168],"group":[169,172,176],"2,":[170],"15.7%;":[171],"3,":[173],"42.0%;":[174],"4,":[177],"48.2%.":[178],"among":[183],"who":[185],"taking":[187],"spironolactone-containing":[188],"sustained":[191],"6":[193],"12":[195],"mo.":[196],"This":[197],"suggests":[199],"offers":[204],"valuable":[206],"adjuvant":[207],"when":[209],"ACEI":[212],"for":[214],"proteinuria.":[218,235],"Results":[219],"suggest":[220],"no":[221],"reduce":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2147273166","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":25}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
